Nadir ULU, Alper Bektaş İSKİT, Cenk SÖKMENSÜER, Mustafa Oğuz GÜÇ

The effects of aspirin, flurbiprofen, and NO-donating acetylsalicylic acid(NCX 4016) on mice models of endotoxic and septic shock

Background/aim: Nitric oxide-donating nonsteroidal antiinflammatory drugs (NO-NSAIDs) are a promising new class of antiinflammatory agents, which are obtained by adding NO-donating moieties to the existing conventional NSAID molecules. The aim of this study was to investigate the effects of aspirin, flurbiprofen, and NO-donating acetylsalicylic acid (NCX 4016) on cecal ligation and puncture (CLP) and endotoxin-induced septic shock (LPS) models in mice. Materials and methods: Overall survival and spleen and liver weights were monitored in LPS and CLP models. Histopathological examinations of liver and spleen were performed at the end of the experimental protocols. Results: NCX 4016 was able to reverse the increased spleen weight in CLP-operated animals, whereas aspirin or flurbiprofen did not. Similar to the results of the CLP model, none of the drugs modified the survival rates in the LPS model. Flurbiprofen in particular produced significant histopathological damage in spleens and livers, which was less significant with aspirin. NCX 4016 did not cause any liver damage. Conclusion: NCX 4016 has the potential to be used in septic states, while special attention has to be paid to the effects of aspirin and flurbiprofen on the liver and spleen.

Anahtar Kelimeler:

Aspirin, flurbiprofen, NCX 4016, septic shock, cecal ligation and puncture, hepatotoxicity

The effects of aspirin, flurbiprofen, and NO-donating acetylsalicylic acid(NCX 4016) on mice models of endotoxic and septic shock

Keywords:

Aspirin, flurbiprofen, NCX 4016, septic shock, cecal ligation and puncture, hepatotoxicity,

PDF

___

Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G et al. 2001 SCCM/ ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intens Care Med 2003; 29: 530–538.
Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29: 1303–1310.
Tsiotou AG, Sakorafas GH, Anagnostopoulos G, Bramis J. Septic shock; current pathogenetic concepts from a clinical perspective. Med Sci Monit 2005; 11: 76–85.
Piepot HA, Groeneveld AB, van Lambalgen AA, Sipkema P. Endotoxin impairs endothelium-dependent vasodilation more in the coronary and renal arteries than in other arteries of the rat. J Surg Res 2003; 110: 413–418.
Del Soldato P, Sorrentino R, Pinto A. NO-aspirins: a class of new anti-inflammatory and antithrombotic agents. Trends Pharmacol Sci 1999; 20: 319–323.
Wallace JL, Del Soldato P. The therapeutic potential of NO- NSAIDs. Fund Clin Pharmacol 2003; 17: 11–20.
Wallace JL, Cirino G, McKnight GW, Elliott SN. Reduction of gastrointestinal injury in acute endotoxic shock by flurbiprofen nitroxybutylester. Eur J Pharmacol 1995; 280: 63–68.
Anuar F, Whiteman M, Bhatia M, Moore PK. Flurbiprofen and its nitric oxide-releasing derivative protect against septic shock in rats. Inflamm Res 2006; 55: 498–503.
Marshall M, Keeble J, Moore PK. Effect of a nitric oxide releasing derivative of paracetamol in a rat model of endotoxaemia. Brit J Pharmacol 2006; 149: 516–522.
Whittle BJ. Nitric oxide and the gut injury induced by non- steroidal anti-inflammatory drugs. Inflammopharmacology 2003; 11: 415–422.
Gray GA, Furman BL, Parratt JR. Endotoxin-induced impairment of vascular reactivity in the pithed rat: role of arachidonic acid metabolites. Circ Shock 1990; 31: 395–406.
Nagase T, Uozumi N, Ishii S, Kume K, Izumi T, Ouchi Y, Shimizu T. Acute lung injury by sepsis and acid aspiration: a key role for cytosolic phospholipase A2. Nat Immunol 2000; 1: 42–46.
Hauser B, Bracht H, Matejovic M, Radermacher P, Venkatesh B. Nitric oxide synthase inhibition in sepsis? Lessons learned from large-animal studies. Anesth Analg 2005; 101: 488–498.
Wink DA, Miranda KM, Espey MG, Pluta RM, Hewett SJ, Colton C, Vitek M, Feelisch M, Grisham MB. Mechanisms of the antioxidant effects of nitric oxide. Antioxid Redox Sign 2001; 3: 203–213.
Springall DR. Nitric oxide: friend and foe. J Pathol 1995; 175: 165–166.
Thiemermann C, Vane J. Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur J Pharmacol 1990; 182: 591–595.
Guc MO. Vascular responsiveness to vasoactive agents in endotoxemia. PhD, University of Strathclyde, Glasgow, UK, 1992.
Guc MO, Furman BL, Parratt JR. Endotoxin-induced impairment of vasopressor and vasodepressor responses in the pithed rat. Brit J Pharmacol 1990; 101: 913–919.
Guc MO, Gray GA, Furman BL, Parratt JR. Endotoxin-induced impairment of vasodepressor responses in the pithed rat. Eur J Pharmacol 1991; 204: 63–70.
Schulz R, Nava E, Moncada S. Induction and potential biological relevance of a Ca(2+)-independent nitric oxide synthase in the myocardium. Brit J Pharmacol 1995; 105: 575– 580.
Schilling J, Cakmakci M, Bättig U, Geroulanos S. A new approach in the treatment of hypotension in human septic shock by NG-monomethyl-L-arginine, an inhibitor of the nitric oxide synthetase. Intens Care Med 1993; 19: 227–231.
Iskit AB, Sungur A, Gedikoglu G, Guc MO. The effects of bosentan, aminoguanidine and L-canavanine on mesenteric blood flow, spleen and liver in endotoxaemic mice. Eur J Pharmacol 1999; 379: 73–80.
Takala J. Determinants of splanchnic blood flow. Brit J Anaesth 1996; 77: 50–58.
Kavuklu B, Iskit AB, Guc MO, Ilhan M, Sayek I. Aminoguanidine attenuates endotoxin-induced mesenteric vascular hyporeactivity. Brit J Surg 2000; 87: 448–453.
Iskit AB, Guc MO. The timing of endothelin and nitric oxide inhibition affects survival in a mice model of septic shock. Eur J Pharmacol 2001; 414: 281–287.
Iskit AB, Senel I, Sokmensuer C, Guc MO. Endothelin receptor antagonist bosentan improves survival in a murine caecal ligation and puncture model of septic shock. Eur J Pharmacol 2004; 506: 83–88.
Baker CC, Chaudry IH, Gaines HO, Baue AE. Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery 1983; 94: 331–335.
Yang S, Chung CS, Ayala A, Chaudry IH, Wang P. Differential alterations in cardiovascular responses during the progression of polymicrobial sepsis in the mouse. Shock 2002; 17: 55–60.
Remick D, Manohar P, Bolgos G, Rodriguez J, Moldawer L, Wollenberg G. Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture. Shock 1995; 4: 89–95.
Brzozowska I, Targosz A, Sliwowski Z, Kwiecien S, Drozdowicz D, Pajdo R, Konturek PC, Brzozowski T, Pawlik M, Konturek SJ et al. Healing of chronic gastric ulcers in diabetic rats treated with native aspirin, nitric oxide (NO)-derivative of aspirin and cyclooxygenase (COX)-2 inhibitor. J Physiol Pharmacol 2004; 55: 773–790.
Tunçtan B, Korkmaz B, Yıldırım H, Tamer L, Atik U, Buharalıoğlu K. Reversal of endotoxin-induced hypotension by inhibition of inducible nitric oxide synthase activity is associated with improved oxidative status in rat heart. Turk J Med Sci 2006; 36: 71–80.